aTyr Pharma Statistics Share Statistics aTyr Pharma has 69.01M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 69.01M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 16.46% Shares Floating 67.12M Failed to Deliver (FTD) Shares 45,711 FTD / Avg. Volume 9.5%
Short Selling Information The latest short interest is 351.2K, so 0% of the outstanding
shares have been sold short.
Short Interest 351.2K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.06
Valuation Ratios The PE ratio is -1.8 and the forward
PE ratio is -47.5.
aTyr Pharma's PEG ratio is
0.17.
PE Ratio -1.8 Forward PE -47.5 PS Ratio 490.29 Forward PS 1.6 PB Ratio 1.65 P/FCF Ratio 0 PEG Ratio 0.17
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for aTyr Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.48,
with a Debt / Equity ratio of 0.19.
Current Ratio 5.48 Quick Ratio 5.48 Debt / Equity 0.19 Debt / EBITDA -0.21 Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $4.2K Profits Per Employee $-1.14M Employee Count 56 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 25% in the
last 52 weeks. The beta is 1.19, so aTyr Pharma's
price volatility has been higher than the market average.
Beta 1.19 52-Week Price Change 25% 50-Day Moving Average 1.73 200-Day Moving Average 1.59 Relative Strength Index (RSI) 39.57 Average Volume (20 Days) 480,976
Income Statement In the last 12 months, aTyr Pharma had revenue of 235K
and earned -64.02M
in profits. Earnings per share was -0.84.
Revenue 235K Gross Profit n/a Operating Income -67.91M Net Income -64.02M EBITDA -64.02M EBIT -64.02M Earnings Per Share (EPS) -0.84
Full Income Statement Balance Sheet The company has 11.05M in cash and 13.28M in
debt, giving a net cash position of -2.23M.
Cash & Cash Equivalents 11.05M Total Debt 13.28M Net Cash -2.23M Retained Earnings -532.05M Total Assets 97.25M Working Capital 72.59M
Full Balance Sheet Margins
Gross Margin n/a Operating Margin -28899.57% Pretax Margin -27243.83% Profit Margin -27243.83% EBITDA Margin -27243.83% EBIT Margin -28899.57% FCF Margin n/a
Dividends & Yields LIFE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for LIFE is $35,
which is 1742.1% higher than the current price. The consensus rating is "Buy".
Price Target $35 Price Target Difference 1742.1% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 1, 2019. It was a
backward
split with a ratio of 1:14.
Last Split Date Jul 1, 2019 Split Type backward Split Ratio 1:14
Scores Altman Z-Score -5.89 Piotroski F-Score 3
